Transient abnormal myelopoiesis in Down syndrome: Experience of long term follow up from a single tertiary center in Thailand
- 24 May 2022
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 40 (2) , 108-116
Abstract
Transient abnormal myelopoiesis (TAM) is a unique disease occurring in Down syndrome (DS) infants from which most patients have spontaneous remission. This study aimed to evaluate the incidence and outcomes of TAM in a tertiary center in Thailand. We reviewed the records of 997 DS patients diagnosed between June 1993 and October 2019. From the 997 DS patients, 32 had been diagnosed with TAM. The incidence of TAM was 3.2% and an overall survival rate of 87.5%. A total of 2/28 who survived (7.1%) subsequently developed AML-DS at the ages of 2.1 and 4.5 years, respectively. The risk factors related with death included maternal multiparity, sepsis, skin bleeding, subcutaneous nodules, high WBC count, low hemoglobin, and elevated AST level. AbbreviationsKeywords
This publication has 23 references indexed in Scilit:
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Blood, 2011
- Risk factors for early death in neonates with Down syndrome and transient leukaemiaBritish Journal of Haematology, 2008
- Treatment and prognostic impact of transient leukemia in neonates with Down syndromeBlood, 2008
- Incidence and clinical implications of GATA1 mutations in newborns with Down syndromeBlood, 2007
- Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98Journal of Clinical Oncology, 2006
- A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481Blood, 2006
- Tumour lysis syndrome: new therapeutic strategies and classificationBritish Journal of Haematology, 2004
- Leukemia and/or myeloproliferative syndrome in neonates with Down SyndromeSeminars in Perinatology, 1997
- Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome.Journal of Clinical Pathology, 1995
- Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphomaThe American Journal of Medicine, 1993